No matter what the doom-mongers would have you believe, our last issue of 2015 reveals that the market will always have more ups than downs. And there are plenty of reasons for optimism in 2016. New Zealanders’ track record at retirement for one, always better with Britannia in the mix, although we advise against complacency. The new anti-cancer drug Keytruda for another – talk to us about ensuring how you can be funded. And lastly we discuss just what the perfect long-term Christmas present could be for your loved ones.
Disclaimer: This publication has been prepared for your general information. While all care has been taken in the preparation of this publication, no warranty is given as to the accuracy of the information and no responsibility is taken for any errors or omissions. This publication does not constitute financial or insurance product advice. It may not be relevant to individual circumstances. Nothing in this publication is, or should be taken as, an offer, invitation, or recommendation to buy, sell, or retain any investment in or make any deposit with any person. You should seek professional advice before taking any action in relation to the matters dealt within this publication. No part of this publication may be reproduced without prior written permission from our company.
© Britannia Financial Services Ltd.
